Science Explorer Interactive view Map
Company · Seoul · ??

Korean Drug Co.

nicepharma.comROR OpenAlex
Research works
3
▼ 88% vs 2013–17
Citations
52
19.2 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
82%
world 28%

Not ranked overall: Korean Drug Co. is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Korean Drug Co. publish most on?

By volume in 2022–2025: Genetic factors in colorectal cancer, Ferroptosis and cancer prognosis, Cytokine Signaling Pathways and Interactions and Inflammatory mediators and NSAID effects.

Genetic factors in colorectal cancer: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksInflammatory mediators and NSAID effects: 0 fractional worksCoenzyme Q10 studies and effects: 0 fractional worksChemical and Physical Pr…0Chemical and Physical Properties in Aqueous Solutions: 0 fractional worksFree Radicals and Antioxidants: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksEicosanoids and Hyperten…0Eicosanoids and Hypertension Pharmacology: 0 fractional works
Pathology and Forensic MedicinePulmonary and Respiratory MedicineOncologyPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  2. 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  3. 3 Cytokine Signaling Pathways and Interactions Oncology 0 works
  4. 4 Inflammatory mediators and NSAID effects Pharmacology 0 works
  5. 5 Coenzyme Q10 studies and effects Molecular Biology 0 works
  6. 6 Chemical and Physical Properties in Aqueous Solutions Filtration and Separation 0 works
  7. 7 Free Radicals and Antioxidants Organic Chemistry 0 works
  8. 8 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  9. 9 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.5%not open18.5%

World: 28% of research is openly available.

with international co-authors10.7%domestic only89.3%

World: 19% is written across borders.

How has Korean Drug Co.'s research output changed?

Output in 2018–2022 was 88% lower than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.